18-66505173-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_021153.4(CDH19):c.1958C>A(p.Ala653Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000961 in 1,613,228 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0047 ( 4 hom., cov: 31)
Exomes 𝑓: 0.00057 ( 3 hom. )
Consequence
CDH19
NM_021153.4 missense
NM_021153.4 missense
Scores
8
5
5
Clinical Significance
Conservation
PhyloP100: 9.33
Genes affected
CDH19 (HGNC:1758): (cadherin 19) This gene is one of three related type II cadherin genes situated in a cluster on chromosome 18. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein containing five extracellular cadherin repeats. Loss of cadherins may be associated with cancer formation. Alternative splicing results in multiple transcript variants for this gene. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.014622867).
BP6
Variant 18-66505173-G-T is Benign according to our data. Variant chr18-66505173-G-T is described in ClinVar as [Benign]. Clinvar id is 3056634.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4_exome allele frequency = 0.000571 (835/1461172) while in subpopulation AFR AF= 0.0168 (561/33414). AF 95% confidence interval is 0.0156. There are 3 homozygotes in gnomad4_exome. There are 366 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH19 | NM_021153.4 | c.1958C>A | p.Ala653Asp | missense_variant | 12/12 | ENST00000262150.7 | NP_066976.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH19 | ENST00000262150.7 | c.1958C>A | p.Ala653Asp | missense_variant | 12/12 | 1 | NM_021153.4 | ENSP00000262150 | P1 | |
CDH19 | ENST00000579658.5 | c.*304C>A | 3_prime_UTR_variant, NMD_transcript_variant | 12/12 | 1 | ENSP00000463085 | ||||
CDH19 | ENST00000540086.5 | c.*115C>A | 3_prime_UTR_variant | 10/10 | 2 | ENSP00000439593 |
Frequencies
GnomAD3 genomes AF: 0.00469 AC: 712AN: 151938Hom.: 4 Cov.: 31
GnomAD3 genomes
AF:
AC:
712
AN:
151938
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00119 AC: 299AN: 250668Hom.: 2 AF XY: 0.000945 AC XY: 128AN XY: 135490
GnomAD3 exomes
AF:
AC:
299
AN:
250668
Hom.:
AF XY:
AC XY:
128
AN XY:
135490
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000571 AC: 835AN: 1461172Hom.: 3 Cov.: 31 AF XY: 0.000503 AC XY: 366AN XY: 726928
GnomAD4 exome
AF:
AC:
835
AN:
1461172
Hom.:
Cov.:
31
AF XY:
AC XY:
366
AN XY:
726928
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00470 AC: 715AN: 152056Hom.: 4 Cov.: 31 AF XY: 0.00463 AC XY: 344AN XY: 74298
GnomAD4 genome
AF:
AC:
715
AN:
152056
Hom.:
Cov.:
31
AF XY:
AC XY:
344
AN XY:
74298
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
52
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
175
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CDH19-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 30, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at